Allergan plc (NYSE: AGN) announced that it has acquired Topokine Therapeutics, a privately held, clinical-stage biotechnology company focused ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE